Case Report
Published on 01 Nov 2024
Case Report: Anaphylaxis caused by traditional Chinese medicine in a patient with pollinosis
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1470638
- 180 views
Type at least 3 characters
53 articles
Articles
Mini Review
Published on 18 Oct 2024
When allergies have no name: is idiopathic anaphylaxis driven by co-factors?
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1468945
- 447 views
Case Report
Published on 18 Oct 2024
Case Report: Multidisciplinary management of a patient with indolent systemic mastocytosis and refractory symptoms
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1401187
- 735 views
Case Report
Published on 11 Oct 2024
A case report of food-dependent exercise-induced anaphylaxis (FDEIA) treated with omalizumab
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1472320
- 481 views
Original Research
Published on 30 Aug 2024
Single center experience with more than 600 drug desensitization in Colombia
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1460326
- 539 views
Mini Review
Published on 26 Aug 2024
Rare causes of pediatric anaphylaxis due to obscure allergens
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1456100
- 905 views
Original Research
Published on 06 Aug 2024
Drug fever—an immune-mediated delayed type hypersensitivity reaction to Vinca alkaloids in pediatric oncology patients, possibly mediated by cysteinyl leukotrienes
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1361403
- 604 views
Case Report
Published on 11 Mar 2024
Case Report: Mast cell anergy: absence of symptoms after accidental re-exposure to amoxicillin/clavulanic acid 3 days after anaphylaxis
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1366922
- 1,628 views
Mini Review
Published on 07 Feb 2024
Recent findings on drug hypersensitivity in children
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2024.1330517
- 2,371 views
Brief Research Report
Published on 16 Jan 2024
Feasibility of a drug allergy registry-based excipient allergy database and call for universal mandatory drug ingredient disclosure: the case of PEG
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1331036
- 1,106 views
Correction
Published on 12 Jan 2024
Corrigendum: Approach for delabeling beta-lactam allergy in children
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1361973
- 809 views
Review
Published on 14 Dec 2023
Potential and limitations of epitope mapping and molecular targeting in Hymenoptera venom allergy
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1327391
- 2,280 views
- 1 citation
Review
Published on 15 Nov 2023
Approach for delabeling beta-lactam allergy in children
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1298335
- 3,022 views
- 2 citations
Editorial
Published on 19 Sep 2023
Editorial: Antibiotic allergy de-labelling and management
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1278690
- 1,073 views
- 1 citation
Brief Research Report
Published on 31 Jul 2023
Use of a beta-lactam graded challenge process for inpatients with self-reported penicillin allergies at an academic medical center
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1161683
- 3,066 views
- 1 citation
Case Report
Published on 27 Jul 2023
Severe exercise-induced anaphylaxis in a hot and humid area successfully treated with omalizumab: a case report
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2023.1228495
- 1,997 views
- 3 citations